The chick chorioallantoic membrane imaging method as a platform to evaluate vasoactivity and assess irritancy of compounds

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 8, 2012, Pages 1128-1137

  Tay, Stephanie L M ^a   Heng, Paul W S ^a   Chan, Lai Wah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Irritancy; Preformulation development; Vasodilation; Vessel diameter

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ALCOHOL; CAFFEINE; GLUCAGON; GLUCOSE; GLYCEROL; GLYCERYL TRINITRATE; NICOTINE; PROPRANOLOL; SODIUM CHLORIDE;

ACCURACY; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD VESSEL DIAMETER; BLOOD VESSEL REACTIVITY; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; HYPEREMIA; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING; IN VIVO STUDY; NONHUMAN; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD VESSELS; CAFFEINE; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DRUG EVALUATION, PRECLINICAL; GLUCAGON; GLYCEROL; HOMEOSTASIS; IRRITANTS; NICOTINE; PROPRANOLOL; SOLVENTS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 84863720706     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01506.x     Document Type: Article

References (46)

1. Qvist MH, et al,. Evaluation of Gottingen minipig skin for transdermal in vitro permeation studies. Eur J Pharm Sci 2000; 11: 59-68. (Pubitemid 30410845)
2. Gibaldi M,. Gibaldi's Drug Delivery Systems in Pharmaceutical Care., Desai A, Lee M,. Bethesda, MD: American Society of Health-System Pharmacists, 2007.
3. Tay SL, et al,. An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies. J Pharm Pharmacol 2011; 63: 1283-1289.
4. Romanoff AL,. The Avian Embryo; Structural and Functional Development. New York: The Macmillan Company, 1960.
5. Fuchs A, Lindenbaum ES,. The two- and three-dimensional structure of the microcirculation of the chick chorioallantoic membrane. Acta Anat (Basel) 1988; 131: 271-275. (Pubitemid 18098141)
6. Valdes TI, et al,. The chick chorioallantoic membrane as a novel in vivo model for the testing of biomaterials. J Biomed Mater Res 2002; 62: 273-282. (Pubitemid 34988505)
7. Burggren W, et al,. Body, eye, and chorioallantoic vessel growth are not dependent on cardiac output level in day 3-4 chicken embryos. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1399-R1406. (Pubitemid 39532224)
8. Spielmann H, et al,. IRAG working group 2. CAM-based assays. Interagency Regulatory Alternatives Group. Food Chem Toxicol 1997; 35: 39-66.
9. Dimitropoulou C, et al,. The vascular architecture of the chick chorioallantoic membrane: sequential quantitative evaluation using corrosion casting. Angiogenesis 1998; 2: 255-263. (Pubitemid 128513125)
10. Reizis A, et al,. Regional and developmental variations of blood vessel morphometry in the chick embryo chorioallantoic membrane. J Exp Biol 2005; 208 (Pt 13): 2483-2488. (Pubitemid 41080421)
11. DeFouw DO, et al,. Mapping of the microcirculation in the chick chorioallantoic membrane during normal angiogenesis. Microvasc Res 1989; 38: 136-147.
12. Mysliveckova A, Rychter Z,. Electron microscopy analysis of differentiation of the wall and capillary bed of the chick embryo allantochorion. Folia Morphol (Praha) 1975; 23: 306-319.
13. Flyckt VMM, et al,. Modelling the impact of blood flow on the temperature distribution in the human eye and the orbit: fixed heat transfer coefficients versus the Pennes bioheat model versus discrete blood vessels. Phys Med Biol 2006; 51: 5007-5021. (Pubitemid 44429857)
14. Moens AL, et al,. Flow-mediated vasodilation-A diagnostic instrument, or an experimental tool? Chest 2005; 127: 2254-2263.
15. Ribatti D, et al,. The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis. Curr Pharm Biotechnol 2000; 1: 73-82.
16. Thompson WD, Brown FI,. Quantitation of histamine-induced angiogenesis in the chick chorioallantoic membrane: mode of action of histamine is indirect. Int J Microcirc Clin Exp 1987; 6: 343-357.
17. Davis G, Johns EJ,. The effect of angiotensin II and vasopressin on renal haemodynamics. J Med Eng Technol 1990; 14: 197-200. (Pubitemid 20321741)
18. Vickerman MB, et al,. VESGEN 2D: automated, user-interactive software for quantification and mapping of angiogenic and lymphangiogenic trees and networks. Anat Rec (Hoboken) 2009; 292: 320-332.
19. Tay SL, et al,. The CAM-LDPI method: a novel platform for the assessment of drug absorption. J Pharm Pharmacol 2011. DOI: 10.1111/j.2042-7158.2011.01431. x.
20. Kind C,. The development of the circulating blood volume of the chick embryo. Anat Embryol (Berl) 1975; 147: 127-132.
21. Guyton AC,. Textbook of Medical Physiology, 10th edn. Philadelphia, PA: Saunders, 2000. xxxii, 1064 p.: ill., port.
22. Luepke NP,. Hens egg chorioallantoic membrane test for irritation potential. Food Chem Toxicol 1985; 23: 287-291. (Pubitemid 15004660)
23. Tavaszi J, Budai P,. The use of HET-CAM test in detecting the ocular irritation. Commun Agric Appl Biol Sci 2007; 72: 137-141.
24. Ernest JT,. Blood-flow in normal and abnormal retinal-vessels. Trans Ophthalmol Soc U K 1980; 100: 343-345.
25. Hjortsjo C, et al,. In vivo and in vitro irritation testing of low concentrations of hydrofluoric acid. Acta Odontol Scand 2009; 6: 360-365.
26. Forough R, et al,. Role of AKT/PKB signaling in fibroblast growth factor-1 (FGF-1)-induced angiogenesis in the chicken chorioallantoic membrane (CAM). J Cell Biochem 2005; 94: 109-116. (Pubitemid 41420329)
27. Zaman RT, et al,. Perfusion in hamster skin treated with glycerol. Lasers Surg Med 2009; 41: 492-503.
28. Thorfinn J, et al,. Perfusion of the skin of the buttocks in paraplegic and tetraplegic patients, and in healthy subjects after a short and long load. Scand J Plast Reconstr Surg Hand Surg 2006; 40: 153-160.
29. Czernin J, Waldherr C,. Cigarette smoking and coronary blood flow. Prog Cardiovasc Dis 2003; 45: 395-404. (Pubitemid 36403112)
30. Galanzha EI, et al,. Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening. World J Gastroenterol 2007; 13: 192-218.
31. Leighton J, et al,. The chick embryo in toxicology: an alternative to the rabbit eye. Food Chem Toxicol 1985; 23: 293-298. (Pubitemid 15004661)
32. Debbasch C, et al,. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition. Food Chem Toxicol 2005; 43: 155-165. (Pubitemid 39575743)
33. Sinha VR, Kaur MP,. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000; 26: 1131-1140.
34. Puddey IB, et al,. Alcohol and endothelial function: a brief review. Clin Exp Pharmacol Physiol 2001; 28: 1020-1024. (Pubitemid 34053515)
35. Altura BM, et al,. Alcohol-induced spasms of cerebral blood-vessels-relation to cerebrovascular accidents and sudden-death. Science 1983; 220: 331-333. (Pubitemid 13118494)
36. Yong T, et al,. In vivo responses of allografted cerebral parenchymal arterioles to ethanol and angiotensin II: effect of calcium-channel blockade. Int J Microcirc Clin Exp 1992; 11: 417-424.
37. Zhang A, et al,. Ethanol-induced contraction of cerebral-arteries in diverse mammals and its mechanism of action. Eur J Pharmacol 1993; 248: 229-236. (Pubitemid 23296341)
38. Altura BM, et al,. Effects of ethanol on terminal arterioles and muscular venules: direct observations on the microcirculation. J Cardiovasc Pharmacol 1979; 1: 97-113. (Pubitemid 10248760)
39. Mayhan WG, Didion SP,. Acute effects of ethanol on responses of cerebral arterioles. Stroke 1995; 26: 2097-2101.
40. Farah AE,. Glucagon and the circulation. Pharmacol Rev 1983; 35: 181-217. (Pubitemid 14216353)
41. Tolins JP,. Mechanisms of glucagon-induced renal vasodilation: role of prostaglandins and endothelium-derived relaxing factor. J Lab Clin Med 1992; 120: 941-948. (Pubitemid 23002904)
42. Calabrese EJ,. Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted. Arch Toxicol 2009; 83: 227-247.
43. Riksen NP, et al,. Human in vivo research on the vascular effects of adenosine. Eur J Pharmacol 2008; 585: 220-227.
44. Szabadi E,. A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol 1977; 69: 101-112. (Pubitemid 8215873)
45. Calabrese EJ, Baldwin LA,. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci 2003; 71: 246-250. (Pubitemid 36285016)
46. Calabrese EJ,. Hormesis and medicine. Br J Clin Pharmacol 2008; 66: 594-617.